Your browser doesn't support javascript.
loading
The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel.
van Zuylen, L; Sparreboom, A; van der Gaast, A; van der Burg, M E; van Beurden, V; Bol, C J; Woestenborghs, R; Palmer, P A; Verweij, J.
Affiliation
  • van Zuylen L; Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital, Rotterdam, The Netherlands. l.van.zuylen@hetnet.nl
Clin Cancer Res ; 6(4): 1365-71, 2000 Apr.
Article in En | MEDLINE | ID: mdl-10778964
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Benzazepines / Paclitaxel / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Taxoids / Neoplasms / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2000 Type: Article Affiliation country: Netherlands
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Benzazepines / Paclitaxel / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Taxoids / Neoplasms / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2000 Type: Article Affiliation country: Netherlands